Fitness Influencer Examines Claim Olympians Shouldn’t Be Allowed To Be On Peptides

Fitness influencer James Smith recently weighed in on the ongoing debate about whether weight loss treatments should be banned from Olympic competition.

Smith began by clarifying the landscape of peptide medications currently available, explaining that weight loss treatments fall into the peptide category. He outlined the progression from semaglutide (found in Ozempic and Wegovy) to tirzepatide (Mounjaro) and retatrutide, the most advanced triple agonist currently available. He also mentioned other popular peptides like GHK-Cu, referred to as a beauty peptide for skin and hair benefits, and growth hormone secretagogues.

Regarding the performance enhancement question, Smith expressed skepticism about them providing a competitive advantage for Olympians. “Most Olympians probably have problems consuming enough, not eating enough,” he noted.

While he acknowledged potential benefits from reducing junk food cravings and improving food quality, he emphasized that “there aren’t really many Olympic sports that favor being shredded.”

Smith drew a critical distinction between physique competitors and athletes. He explained: “If we look at a spectrum in front of us, physique competitors on one side and dare I say a HYROX athlete on the other side, the person competing in HYROX will be at their psychological and physiological best on that day and the person in their physique will be on their worst. So when it comes to athleticism and performing your best, I would say that weight loss d**gs take us in the opposite direction.”

The influencer did acknowledge potential applications in specific scenarios, such as rugby players managing weight to prevent health issues from excess mass. He also shared personal experience using tirzepatide during travel and recovery periods to maintain mental health by avoiding unwanted weight gain.

On the question of whether these treatments should be banned, Smith remained ambivalent.

“I could appreciate if it goes both ways to be perfectly honest,” he said, noting that most Olympians work with full-time nutritionists anyway. However, he expressed concern about establishing precedents: “Once you start permitting some form of peptide to be used in the Olympics, then what happens next?”

Smith emphasized that these medications are primarily designed for people who are significantly overweight, citing research spanning over a decade that demonstrates clear health benefits. For individuals carrying 88 lbs (40 kg) of excess weight, he argued the health advantages far outweigh potential side effects.